Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial

N Zhang, H Jiang, H Dai, S Huang, Q Zhao… - Renal …, 2024 - Taylor & Francis
Background This study aims to undertake a comprehensive assessment of the effectiveness
and safety profile of Mahuang Fuzi and Shenzhuo Decoction (MFSD) in the management of …

[HTML][HTML] Effect of Mahuang Fuzi and Shenzhuo decoction on idiopathic membranous nephropathy: a multicenter, nonrandomized, single-arm clinical trial

Z Dong, H Dai, Y Gao, H Jiang, M Liu, F Liu… - Frontiers in …, 2021 - frontiersin.org
Objective: To explore the clinical effect of Mahuang Fuzi and Shenzhuo Decoction on
idiopathic membranous nephropathy. Methods: This study is a multicenter, nonrandomized …

[HTML][HTML] Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: a systematic review and meta-analysis

Z Lu, W Liu, H Gao, W Chen, W Ge, F Li, Y Deng - PloS one, 2021 - journals.plos.org
Background Idiopathic membranous nephropathy (IMN) is one of the most common causes
of nephrotic syndrome in adults involving multiple targets and factors. The effect of …

[HTML][HTML] Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis

W Shan, H Guan, H Gu, R Wang, X Huang, P Li, Y Xie… - Heliyon, 2024 - cell.com
Background Idiopathic membranous nephropathy (IMN) is a rare autoimmune disorder that
causes nephrotic syndromes in adults. Conventional immunosuppressive therapies often …

Efficacy of Traditional Chinese Medicine Regimen Jian Pi Qu Shi Formula for Refractory Patients with Idiopathic Membranous Nephropathy: A Retrospective Case …

B Shi, R Zhang, Y Liang, X Wang… - Evidence‐Based …, 2018 - Wiley Online Library
Background. The treatment of adult refractory idiopathic membranous nephropathy with
steroid and other immunosuppressant‐resistant nephrotic syndromes can be a significant …

Clinical practice guideline for Chinese medicine in the treatment of idiopathic membranous nephropathy (2021)

L YANG, P SU, K BAO - Chinese General Practice, 2023 - chinagp.net
In China, idiopathic membranous nephropathy (IMN) accounts for 24.9% of glomerular
diseases, the second highest share, and is increasing year by year. Chinese medicine has …

[HTML][HTML] Real-world effects of Chinese herbal medicine for idiopathic membranous nephropathy (REACH-MN): Protocol of a registry-based cohort study

L Yang, X Chen, C Li, P Xu, W Mao, X Liang… - Frontiers in …, 2022 - frontiersin.org
Introduction: Some encouraging findings of Chinese herbal medicine (CHM) in management
of idiopathic membranous nephropathy (IMN) obtained in the setting of clinical trials are …

Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy

JAJG van den Brand, PR van Dijk… - Journal of the …, 2014 - journals.lww.com
Abstract Recently published Kidney Disease Improving Global Outcomes (KDIGO)
guidelines recommend limiting the use of immunosuppressive drugs in idiopathic …

[HTML][HTML] Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy

H Cui, FQ Fu, B Liu, WJ Liu, YN Liu - Frontiers in Pharmacology, 2021 - frontiersin.org
Background: Treatment for adult patients with refractory idiopathic membranous
nephropathy (RIMN) by conventional immunosuppressive regimens is not satisfactory. This …

[HTML][HTML] Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with …

O Ragy, P Hamilton, A Pathi, AAM Ahmed, S Mitra… - Glomerular …, 2023 - karger.com
Abstract Introduction and Aims: Therapy of primary membranous nephropathy (PMN) with
progressive advanced kidney dysfunction is challenging with limited literature and no clear …